Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Andreas O. Reiff, MD

    TitleProfessor of Clinical Pediatrics
    SchoolKeck School of Medicine of USC
    DepartmentPediatrics
    AddressCHL Mail Stop 60
    Off Campus
    Los Angeles California 90089
    Phone+1 323 361 5524
    vCardDownload vCard
      Other Positions
      TitleDivision Head, Rheumatology


      Collapse Overview 
      Collapse Overview
      Andreas Otto Reiff, MD, is a Professor of Pediatrics at Children's Hospital Los Angeles, Keck School of Medicine and Division Head of the Division of Rheumatology at Children's Hospital Los Angeles. He is also the director of the Pediatric Rheumatology Program at Miller Children's Hospital in Long Beach, California and a Visiting Clinical Associate Professor, Department of Pediatrics, University of Nevada School of Medicine. Dr. Reiff received his medical degree from University Medical School in Freiburg, Germany. Following an internship in internal medicine and surgery at Kantonsspital Liestal in Switzerland, he returned to Freiburg and completed his residency at the University Children's Hospital. He completed a research fellowship in the Division of Rheumatology and Bone Marrow Transplantation at Childrens Hospital Los Angeles between 1993 and 1994, and a fellowship in pediatric rheumatology at University Children's Hospital in Freiburg from 1994 -1996. An avid researcher and investigator, Dr. Reiff's primary research interests include the treatment, management, and genetics of pediatric autoimmune diseases; treatment of inflammatory and degenerative eye diseases, and alternatives to stem cell transplantation. In addition to authoring and co-authoring numerous journal articles, abstracts, reviews, and book chapters, he has lectured on rheumatologic topics nationally and internationally. He is a clinical consultant for several pharmaceutical companies and serves on advisory boards for the Arthritis Foundation, Lupus International, and on several CHLA committees. He is a well known national and international speaker on biologic drug development and the treatment of chronic inflammatory eye diseases. Dr. Reiff is board-certified in pediatrics and pediatric rheumatology by the European Union and the American Board of Pediatrics. He is a member of the Southwestern Pediatric Society, the Pediatric Rheumatology Collaborative Study Group, and the American College of Rheumatology. In addition, he is a founding member of the pediatric rheumatology research network (CARRA). He has received several honors, grants, and awards.


      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016 Oct; 68(10):2514-26. PMID: 27111558.
        View in: PubMed
      2. Felsenstein S, Reiff A, Ramanathan A. Transition of Care and Health-Related Outcomes in Pediatric-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2015 Nov; 67(11):1521-8. PMID: 25939495.
        View in: PubMed
      3. Chang CY, Meyer RM, Reiff A. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy. Arthritis Care Res (Hoboken). 2015 May; 67(5):658-66. PMID: 25220674.
        View in: PubMed
      4. Brunner HI, Silva CA, Reiff A, Higgins GC, Imundo L, Williams CB, Wallace CA, Aikawa NE, Nelson S, Klein-Gitelman MS, Rose SR. Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2015 May; 67(5):1377-85. PMID: 25676588.
        View in: PubMed
      5. Stern S, Clemente G, Reiff A, Ramos MP, Marzan KA, Terreri MT. Treatment of pediatric takayasu arteritis with infliximab and cyclophosphamide: experience from an american-brazilian cohort study. J Clin Rheumatol. 2014 Jun; 20(4):183-8. PMID: 24847743.
        View in: PubMed
      6. Hashkes PJ, Spalding SJ, Hajj-Ali R, Giannini EH, Johnson A, Barron KS, Weisman MH, Pashinian N, Reiff A, Samuels J, Wright D, Lovell DJ, Huang B. The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever. Biomed Res Int. 2014; 2014:854842. PMID: 25147819.
        View in: PubMed
      7. Reiff A, Bassuk AG, Church JA, Campbell E, Bing X, Ferguson PJ. Exome sequencing reveals RAG1 mutations in a child with autoimmunity and sterile chronic multifocal osteomyelitis evolving into disseminated granulomatous disease. J Clin Immunol. 2013 Nov; 33(8):1289-92. PMID: 24122031.
        View in: PubMed
      8. Lovell DJ, Giannini EH, Reiff A, Kimura Y, Li S, Hashkes PJ, Wallace CA, Onel KB, Foell D, Wu R, Biedermann S, Hamilton JD, Radin AR. Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis. Arthritis Rheum. 2013 Sep; 65(9):2486-96. PMID: 23754188.
        View in: PubMed
      9. Reiff A, Weinberg KI, Triche T, Masinsin B, Mahadeo KM, Lin CH, Brown D, Parkman R. T lymphocyte abnormalities in juvenile systemic sclerosis patients. Clin Immunol. 2013 Oct; 149(1):146-55. PMID: 23994768.
        View in: PubMed
      10. Reiff A. Preface. Rheum Dis Clin North Am. 2013 Nov; 39(4):xvii-xviii. PMID: 24182863.
        View in: PubMed
      11. Reiff A, Kadayifcilar S, Ozen S. Rheumatic inflammatory eye diseases of childhood. Rheum Dis Clin North Am. 2013 Nov; 39(4):801-32. PMID: 24182856.
        View in: PubMed
      12. Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff A, Samuels J, Wright DA, Kastner DL, Lovell DJ. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med. 2012 Oct 16; 157(8):533-41. PMID: 23070486.
        View in: PubMed
      13. Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, Sundel RP. Pediatric chronic nonbacterial osteomyelitis. Pediatrics. 2012 Nov; 130(5):e1190-7. PMID: 23071213.
        View in: PubMed
      14. Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O'Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA. Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions. J Rheumatol. 2012 Oct; 39(10):2012-20. PMID: 22859342.
        View in: PubMed
      15. Uribe AG, Huber AM, Kim S, O'Neil KM, Wahezi DM, Abramson L, Baszis K, Benseler SM, Bowyer SL, Campillo S, Chira P, Hersh AO, Higgins GC, Eberhard A, Ede K, Imundo LF, Jung L, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Li SC, Lovell DJ, Mason T, McCurdy D, Muscal E, Nassi L, Rabinovich E, Reiff A, Rosenkranz M, Schikler KN, Singer NG, Spalding S, Stevens AM, Cabral DA. Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol. 2012 Aug; 39(8):1687-97. PMID: 22589257.
        View in: PubMed
      16. Radhakrishna SM, Reiff A, Marzan KA, Azen C, Khemani RG, Rubin S, Menteer J, Brown DE, Shaham B. Pediatric rheumatic disease in the intensive care unit: Lessons learned from 15 years of experience in a tertiary care pediatric hospital. Pediatr Crit Care Med. 2012 May; 13(3):e181-6. PMID: 22561277.
        View in: PubMed
      17. Castillo RD, Garza JX, Shamszadeh M, Reiff A, Marzan KA. Acanthamoeba meningoencephalitis presenting as neuropsychiatric lupus in a pediatric patient. Clin Exp Rheumatol. 2012 Mar-Apr; 30(2):272-6. PMID: 22409906.
        View in: PubMed
      18. Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, Abramson L, Baszis K, Benseler S, Bowyer S, Campillo S, Chira P, Hersh AO, Higgins G, Eberhard A, Ede K, Imundo L, Jung L, Kim S, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Lovell DJ, Mason T, McCurdy D, Nanda K, Nassi L, O'Neil KM, Rabinovich E, Ramsey SE, Reiff A, Rosenkranz M, Schikler K, Stevens A, Wahezi D, Cabral DA. Assessing the Performance of the Birmingham Vasculitis Activity Score at Diagnosis for Children with Antineutrophil Cytoplasmic Antibody-associated Vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol. 2012 May; 39(5):1088-94. PMID: 22337238.
        View in: PubMed
      19. Reiff A. Treatment of Systemic Juvenile Idiopathic Arthritis with Tocilizumab - the Role of Anti-Interleukin-6 Therapy After a Decade of Treatment. Biol Ther. 2012; 2:1. PMID: 24392296.
        View in: PubMed
      20. Sukumaran S, Marzan K, Shaham B, Reiff A. High dose infliximab in the treatment of refractory uveitis: does dose matter? ISRN Rheumatol. 2012; 2012:765380. PMID: 22389806.
        View in: PubMed
      21. Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, Quismorio FP, Reiff A, Myones BL, Kaufman KM, McCurdy D, Harley JB, Silverman E, Kimberly RP, Vyse TJ, Gaffney PM, Moser KL, Klein-Gitelman M, Wagner-Weiner L, Langefeld CD, Armstrong DL, Zidovetzki R. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):E59-67. PMID: 22203994.
        View in: PubMed
      22. Pitukcheewanont P, Bali B, Somanunt S, Reiff A. Scleroderma-like skin changes not involving the hand in a prepubertal male with type I diabetes mellitus: A case report. Dermatoendocrinol. 2011 Oct; 3(4):230-2. PMID: 22259648.
        View in: PubMed
      23. Brunner HI, Mina R, Pilkington C, Beresford MW, Reiff A, Levy DM, Tucker LB, Eberhard BA, Ravelli A, Schanberg LE, Saad-Magalhaes C, Higgins GC, Onel K, Singer NG, von Scheven E, Itert L, Klein-Gitelman MS, Punaro M, Ying J, Giannini EH. Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011 Sep; 63(9):1213-23. PMID: 21618452.
        View in: PubMed
      24. Reiff A, Shaham B, Weinberg KI, Crooks GM, Parkman R. Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis. J Clin Immunol. 2011 Aug; 31(4):615-22. PMID: 21541793.
        View in: PubMed
      25. Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, Higgins G, Gottlieb B, Chon Y, Zhang N, Baumgartner SW. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2010 Nov; 62(11):3259-64. PMID: 20669280.
        View in: PubMed
      26. Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, Dewitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D, Woodward A. Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum. 2009 Nov; 60(11):3413-24. PMID: 19877069.
        View in: PubMed
      27. Hong SD, Reiff A, Yang HT, Migone TS, Ward CD, Marzan K, Shaham B, Phei WC, Garza J, Bernstein B, Stohl W. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients. Arthritis Rheum. 2009 Nov; 60(11):3400-9. PMID: 19877053.
        View in: PubMed
      28. Reiff A. Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases. Curr Rheumatol Rep. 2009 Jul; 11(3):226-32. PMID: 19604468.
        View in: PubMed
      29. Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, Ciobanu V, Kaufman KM, Ojwang JO, Ziegler J, Quismorio FP, Reiff A, Myones BL, Guthridge JM, Nath SK, Bruner GR, Mehrian-Shai R, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Putterman C, Bae SC, Kim YJ, Petri M, Reveille JD, Vyse TJ, Gilkeson GS, Kamen DL, Alarcón-Riquelme ME, Gaffney PM, Moser KL, Merrill JT, Scofield RH, James JA, Langefeld CD, Harley JB, Jacob CO. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 2009 Apr; 60(4):1085-95. PMID: 19333953.
        View in: PubMed
      30. Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, Zhou XJ, Thomas JA, Reiff A, Myones BL, Ojwang JO, Kaufman KM, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, Ziegler J, Kelly JA, Merrill JT, Harley JB, Ramsey-Goldman R, Vila LM, Bae SC, Vyse TJ, Gilkeson GS, Gaffney PM, Moser KL, Langefeld CD, Zidovetzki R, Mohan C. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2009 Apr 14; 106(15):6256-61. PMID: 19329491.
        View in: PubMed
      31. Ilowite N, Porras O, Reiff A, Rudge S, Punaro M, Martin A, Allen R, Harville T, Sun YN, Bevirt T, Aras G, Appleton B. Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol. 2009 Feb; 28(2):129-37. PMID: 18766426.
        View in: PubMed
      32. Marzan KA, Reiff A. Adalimumab in juvenile rheumatoid arthritis/juvenile idiopathic arthritis. Expert Rev Clin Immunol. 2008 Sep; 4(5):549-58. PMID: 20476957.
        View in: PubMed
      33. Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008 Aug 21; 359(8):810-20. PMID: 18716298.
        View in: PubMed
      34. Reiff A. Childhood quality of life in the changing landscape of pediatric rheumatology. J Pediatr (Rio J). 2008 Jul-Aug; 84(4):285-8. PMID: 18688556.
        View in: PubMed
      35. Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008 May; 58(5):1496-504. PMID: 18438876.
        View in: PubMed
      36. Jacob CO, Reiff A, Armstrong DL, Myones BL, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Solomon A, Zidovetzki R. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum. 2007 Dec; 56(12):4164-73. PMID: 18050247.
        View in: PubMed
      37. Reiff A. Ocular complications of childhood rheumatic diseases: uveitis. Curr Rheumatol Rep. 2006 Dec; 8(6):459-68. PMID: 17152145.
        View in: PubMed
      38. Flatø B, Hoffmann-Vold AM, Reiff A, Førre Ø, Lien G, Vinje O. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum. 2006 Nov; 54(11):3573-82. PMID: 17075863.
        View in: PubMed
      39. Aksentijevich I, Remmers EF, Goldbach-Mansky R, Reiff A, Kastner DL. Mutational analysis in neonatal-onset multisystem inflammatory disease: comment on the articles by Frenkel et al and Saito et al. Arthritis Rheum. 2006 Aug; 54(8):2703-4; author reply 2704-5. PMID: 16871551.
        View in: PubMed
      40. Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2006 Jun; 54(6):1987-94. PMID: 16732547.
        View in: PubMed
      41. Reiff A, Lovell DJ, Adelsberg JV, Kiss MH, Goodman S, Zavaler MF, Chen PY, Bolognese JA, Cavanaugh P, Reicin AS, Giannini EH. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. J Rheumatol. 2006 May; 33(5):985-95. PMID: 16583464.
        View in: PubMed
      42. Reiff A. The use of anakinra in juvenile arthritis. Curr Rheumatol Rep. 2005 Dec; 7(6):434-40. PMID: 16303102.
        View in: PubMed
      43. Kimura Y, Pinho P, Walco G, Higgins G, Hummell D, Szer I, Henrickson M, Watcher S, Reiff A. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2005 May; 32(5):935-42. PMID: 15868633.
        View in: PubMed
      44. Reiff A. A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation. Hematology. 2005 Apr; 10(2):79-93. PMID: 16019453.
        View in: PubMed
      45. Henrickson M, Reiff A. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. J Rheumatol. 2004 Oct; 31(10):2055-61. PMID: 15468375.
        View in: PubMed
      46. Reiff A. Developments in the treatment of juvenile arthritis. Expert Opin Pharmacother. 2004 Jul; 5(7):1485-96. PMID: 15212599.
        View in: PubMed
      47. Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, Maldonado-Velázquez MR, Beristain-Manterola R, Maeno N, Takei S, Falcini F, Lepore L, Spencer CH, Pratsidou-Gertsi P, Martini A, Ravelli A. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum. 2004 Jun 15; 51(3):458-64. PMID: 15188334.
        View in: PubMed
      48. Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, Beristain-Manterola R, Maeno N, Takei S, Gerloni V, Spencer CH, Pratsidou-Gertsi P, Ruperto N, Pistorio A, Martini A. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum. 2003 Aug 15; 49(4):501-7. PMID: 12910556.
        View in: PubMed
      49. Reiff A. Long-term outcome of etanercept therapy in children with treatment-refractory uveitis. Arthritis Rheum. 2003 Jul; 48(7):2079-80. PMID: 12847709.
        View in: PubMed
      50. Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum. 2003 Jan; 48(1):218-26. PMID: 12528122.
        View in: PubMed
      51. Klein-Gitelman M, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am. 2002 Aug; 28(3):561-77, vi-vii. PMID: 12380370.
        View in: PubMed